Back

Impact of sacubitril valsartan initiation in patients with HFrEF and severe mitral regurgitation referred for percutaneous mitral repair

27 August 2023 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Complex and novel interventions for heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Maria Rivadeneira Ruiz

San Carlos Clinical University Hospital, Madrid (Spain)

7 More presentations in this session

Presentation thumbnail
Transcatheter endomyocardial alginate-hydrogel injection for treatment of heart failure
Doctor B. Wang (Galway, IE)
Abstract Slides
Presentation thumbnail
Interventional rhythm control is associated with an improved long-term prognosis of patients with atrial fibrillation undergoing transcatheter edge-to-edge mitral valve repair
Doctor C. Waechter (Muenster, DE)
Abstract Slides Video
Presentation thumbnail
The PRELIEVE trial:Final 1-year outcomes of the prospective atrial flow regulator study
Doctor C. Paitazoglou (Luebeck, DE)
Abstract Slides Video
Presentation thumbnail
Tricuspid regurgitation and heart failure: the faith of treated vs untreated cohort in the percutaneous era
Doctor E. Zancanaro (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
A proactive care pathway that improves medical therapy for patients with heart failure with reduced ejection fraction and implantable cardiac devices
Doctor H. Williams (Bristol, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Complex and novel interventions for heart failure

The Event

Event poster

ESC Congress 2023

27 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources